Overview

A PET Study With [11C]PBR-28 and an Experimental Medication, Ethyl Eicosapentaenoic Acid

Status:
Recruiting
Trial end date:
2022-01-19
Target enrollment:
Participant gender:
Summary
This pilot study will ask whether omega three fatty acids have an antidepressant effect in bipolar depression by decreasing brain inflammation.
Phase:
Phase 4
Details
Lead Sponsor:
New York State Psychiatric Institute
Treatments:
Eicosapentaenoic acid ethyl ester